Companies Researching Cancer Treatments By: Amanda Garcia

Slides:

Advertisements

Similar presentations

2nd Panel, Best Practices: “ IPR in Successful University-Industry Collaborations” Dr. Tamar Raz, CEO Hadasit, the Technology Transfer Company of Hadassah.

Advertisements

Geriatric Rounds: Compounds of Medical Need March 28, 2014 Albert Giovenella, Ph.D. Adjunct Asst. Professor of Medicine.

Pharma/BIOTECH industry overview

Targeted Cancer Therapeutics, LLC Investor Presentation.

Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.

Community College Program Welcome. Annual Community College Program Day Organizing Committee Sonia Wallman – Executive Director NBC2 Elaine Johnson –

AMYLIN PHARMACEUTICALS (AMLN) Recent stock price: (1/19/04 close) 52-week range: Market cap: 2.04 Bil Revenue:

January 3, 2003 Kevin Rakin President and Chief Executive Officer Kevin Rakin President and Chief Executive Officer Economic Summit and Outlook 2003.

 Broad-based health care company that discovers, develops, manufactures, and markets products and services  Abbott's main businesses: ◦ Global pharmaceuticals.

The Health Care Sector Analysts: Heather Hund and Emily Butler.

Sector Analysis Healthcare Anurup Upadhyay BUS 416 Investment Management 3/5/14.

Academic Clinical Trial Do’s & Don’ts for Partnering with Pharma CCAF San Diego, CA April 14, 2014 J. Eric Bubbers, Ph.D.

This venture represents the culmination point of over 10 years of participation as a NORD Corporate Council member.

1 Clayton Biotechnologies, Inc. One Riverway, Suite 1520 Houston, Texas Overview of Clayton Biotechnologies,

Entrepreneurship in Biotechnology Columbia University Graduate School of Arts and Sciences BIOT 4180 Columbia University GSAS BIOT 4180.

Pharmaceutical Industry Analysis Nature of the industry: Highly defensive and 15% of U.S. population aged over 60→Highly mature. Main forces are the suppliers,

1 Clayton Biotechnologies, Inc. One Riverway, Suite 1520 Houston, Texas Overview of Clayton Biotechnologies,

Florida Center of Excellence for Biomolecular Identification and Targeted Therapeutics.

European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 Towards the Sixth Framework Programme Parallel Forum V 26 September 2002 Public.

Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.

Case for Support. Blood Cancers More than 1 million North Americans are fighting blood cancers, the third leading cause of cancer deaths. Early detection.

Challenges and opportunities in New Zealand’s pharmaceutical scene Kevin Sheehy – Chief Executive, Medicines New Zealand Dalton Kelly – Chief Executive,

Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.

By Yash Sameer.  Buy: $3.30  Sell: $7.50  Somaxon Pharmaceuticals is a pharmaceutical company focused on the in-licensing, development and commercialization.

Abcd Value through Innovation ABCD. Abcd Value Through Innovation Boehringer Ingelheim is committed to becoming the most innovative research, development.

Todays Clinical Trials. Tomorrow’s Cures. Robert L. Comis, MD 1 National Coalition for Cancer Research “Cancer 101” Congressional Briefing 09/10/14.

1 Michael V. Novinski President and Chief Executive Officer November 6, 2008 Third Quarter 2008 Earnings Conference Call.

1 Clayton Biotechnologies, Inc. One Riverway, Suite 1520 Houston, Texas Overview of Clayton Biotechnologies,

Which has the Human Genome Project most improved in the field of medicine? A. the ability to generate vaccines B. the diagnosis and treatment of disease.

Nasdaq - QCOR.  Healthcare  Biotechnology  Market Cap Billion  Aggressive Growth Stock  Anaheim, California  557 Employees.

Single Patient Use of Investigational Anticancer Agents: An Industry Perspective Gerard T. Kennealey, MD Vice President, Clinical Research, Oncology AstraZeneca.

1 Clayton Biotechnologies, Inc. One Riverway, Suite 1520 Houston, Texas Overview of Clayton Biotechnologies,

Watch List Presentations April 17, 2008 David Light, Phil Rosen, Tim Tyson.

The ELSI Implications of Gene Therapy under the UNESCO Declaration -a Taiwan’s Perspective Panelist ： Lin, Jui-Chu & Wang, Triumph.

Experiences (and frustrations) in Developing a Biotech Company in Idaho.

SEEK is a drug-discovery group that uses a pioneering scientific and commercially-driven approach to create breakthrough medicines which address major.

1 Medication Development for Treatment of Drug Dependence Donald R. Wesson, MD Consultant, CNS Medications Development Chairman, ASAM Medications Development.

Program Coordinator Medication Assistance Program Smilow Cancer Hospital at Yale New Haven Program Coordinator Medication Assistance Program Smilow Cancer.

0 International Medical Cluster (IMC), to be established in Moscow, creates a unique framework for developing healthcare business: –IMC activities are.

Bringing Genomics Home Your DNA: A Blueprint for Better Health Genome British Columbia November 18, 2015 / West Vancouver, BC.

The Use of Milnacipran in Treating Fibromyalgia. MilnacipranMilnacipran, also known as milnacipran hydrochloride or Savella, helps to alleviate the pain.

Cannabis Stock Market The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce,

1 Promotion in Management and Research Tracks in Industry Magdalena Alonso-Galicia, PhD Cardiovascular Diseases Department Merck Research Laboratories.

Global Orphan Drug Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022 Phone No.: +1 (214) id:

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.

CLINICAL TRIALS.

Difference to Generics What can they do for us in the future

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Bioreactor Market to surpass.

Biotechnology R&D.

PHARMACEUTICAL BIOTECHNOLOGY:

GLOBAL SYNTHETIC BIOLOGY MARKET

FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health

Industry Perspective: Expanded Access Programs

Clinical Trials — A Closer Look

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Ultra-low Temperature Freezers.

© Coherent market Insights. All Rights Reserved Peptide Therapeutics Market INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018–2026 © Coherent.

Innovation & the Pharmaceutical Research & Development Industry

Investment Opportunity and

The Different Phases Of Clinical Trials

Suzanne M. Sensabaugh, MS, MBA

Why Use Animals Unit 2-2.

FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health

Dosage Form Design Lecture 1 17/2/2019 Dr. Athmar Dhahir Habeeb

Janssen Pharmaceutical Ltd

Pharmaceuticals Industry

Introduction to Basic Research Methods

Global Specialty Pharmaceuticals Market.

Next Generation Sequencing Market. Report Description and Highlights According to Renub Research market research report “Next Generation Sequencing (NGS)

Expert Speak: How Pharma Companies Can Grow Their Business?

Financial Options when living with Cancer

Presentation transcript:

Companies Researching Cancer Treatments By: Amanda Garcia Company Investment Companies Researching Cancer Treatments By: Amanda Garcia

Applera Acquired by Life Technologies brand under the Thermo Fisher Scientific Corporation in 2006 Thermo Fisher and its brands specialize in laboratory equipment/technology 52-week stock of TFS: High- 182.87 and Low- 139.07 Known partnerships: Seegene, Megaware, Symyx Technologies Inc, and Arkivum

Onyx Pharmaceuticals Biopharmaceutical company that marketed and developed medicines for cancer treatment Acquired by Amgen in 2013 Amgen currently has 33 pre-clinical and clinical targets in various phases; specialize in various illnesses like cancer 52-week stock: High- 184.21 and Low-133.44 Known partnerships: Novartis, Daiichi, Immatics, SiteOne and many others worldwide

United Therapeutics Biotechnology company that specializes in development and commercialization of chronic and life-threatening conditions In 2015, FDA approved a new drug that will treat neuroblastoma, a rare cancer found in children 52-week stock: High- 169.89 and Low- 110.90 Known partnerships: Northwell Health and Memorial Sloan- Kettering Cancer Center

Crucell NV Now a subsidiary of Janssen Pharmaceutical Companies of Johnson & Johnson since 2011 Crucell had specialized in vaccines for infectious diseases Janssen researches and develops treatments in many fields, including oncology 52-week stock: High- 137.08 and Low- 109.32 Have over 400 partnerships worldwide

Mankind Corporation Biopharmaceutical company that focuses on therapeutic products for diseases, such as diabetes Have 1 FDA approved insulin drug called “Afrezza” Developing 3 other medications for clinical trials 52-week stock: High- 5.10 and Low- 0.67 Known partnerships: Juvenile Diabetes Research Foundation, The Leukemia and Lymphoma Society, OneDrop Foundation

Conclusion Most optimal companies to invest in: Janssen Pharmaceuticals and Amgen Both have well-established roots and steady growth Have had consistent development in cancer research Are multinational, with plenty of funding and access to many variables for clinical trials